|
1
|
Blagojevic A, Delaney JA, Lévesque LE,
Dendukuri N, Boivin JF and Brophy JM: Investigation of an
interaction between statins and clopidogrel after percutaneous
coronary intervention: a cohort study. Pharmacoepidemiol Drug Saf.
18:362–369. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization. The top ten
causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index.htmluri.
Accessed September 4, 2007
|
|
3
|
Lemos PA, Hoye A, Goedhart D, et al:
Clinical, angiographic, and procedural predictors of angiographic
restenosis after sirolimus-eluting stent implantation in complex
patients: an evaluation from the Rapamycin-Eluting Stent Evaluated
at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation.
109:1366–1370. 2004. View Article : Google Scholar
|
|
4
|
Lemos PA, Serruys PW, van Domburg RT, et
al: Unrestricted utilization of sirolimus-eluting stents compared
with conventional bare stent implantation in the ‘real world’: The
Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital
(RESEARCH) registry. Circulation. 109:190–195. 2004.PubMed/NCBI
|
|
5
|
Harjai KJ, Sattur S, Orshaw P and Boura J:
Long-term safety and effectiveness of drug-eluting stents compared
to bare metal stents following successful PCI in non-ST-elevation
myocardial infarction: findings from the Guthrie Health Off-Label
StenT (GHOST) Registry. J Interv Cardiol. 25:28–36. 2012.
View Article : Google Scholar
|
|
6
|
Green SM, Selzer F, Mulukutla SR, et al:
Comparison of bare-metal and drug-eluting stents in patients with
chronic kidney disease (from the NHLBI Dynamic Registry). Am J
Cardiol. 108:1658–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stone GW, Ellis SG, Cannon L, et al; TAXUS
V Investigators. Comparison of a polymer-based paclitaxel-eluting
stent with a bare metal stent in patients with complex coronary
artery disease: a randomized controlled trial. JAMA. 294:1215–1223.
2005. View Article : Google Scholar
|
|
8
|
Pfisterer M, Brunner-La Rocca HP, Buser
PT, et al: Late clinical events after clopidogrel discontinuation
may limit the benefit of drug-eluting stents: an observation study
of drug-eluting versus bare-metal stents. J Am Coll Cardiol.
48:2584–2591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee MG, Jeong MH, Ahn Y, et al; Korea
Acute Myocardial Infarction Registry Investigators. Comparison of
paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients
with acute ST-segment elevation myocardial infarction and metabolic
syndrome. Circ J. 75:2120–2127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mauri L, Hsieh WH, Massaro JM, Ho KK,
D’Agostino R and Cutlip DE: Stent thrombosis in randomized clinical
trials of drug-eluting stents. N Eng J Med. 356:1020–1029. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wykrzykowska JJ, Garg S, Onuma Y, et al:
Implantation of the biodegradable polymer biolimus-eluting stent in
patients with high SYNTAX score is associated with decreased
cardiac mortality compared to a permanent polymer sirolimus-eluting
stent: two year follow-up results from the ‘all-comers’ LEADERS
trial. EuroIntervention. 7:605–613. 2011.PubMed/NCBI
|
|
12
|
Zhang RY, Zhang Q, Zhu JZ, et al: Safety
and efficacy of polymer-free paclitaxel-eluting microporous stent
in real-world practice: 1-year follow-up of the SERY-I registry.
Chin Med J (Engl). 124:3521–3526. 2011.PubMed/NCBI
|
|
13
|
Vranckx P, Kint PP, Morel MA, et al:
Identifying stent thrombosis, a critical appraisal of the academic
research consortium (ARC) consensus definitions: a lighthouse and
as a toe in the water. EuroIntervention. 4(Suppl C): C39–44.
2008.PubMed/NCBI
|
|
14
|
Kwan TW, Cherukuri S, Huang Y, et al:
Feasibility and safety of 7F sheathless guiding catheter during
transradial coronary intervention. Catheter Cardiovasc Interv.
80:274–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chieffo A, Morici N, Maisano F, et al:
Percutaneous treatment with drug-eluting stent implantation versus
bypass surgery for unprotected left main stenosis: a single-center
experience. Circulation. 113:2542–2547. 2006. View Article : Google Scholar
|
|
16
|
Virmani R, Guagliumi G, Farb A, et al:
Localized hypersensitivity and late coronary thrombosis secondary
to a sirolimus-eluting stent: should we be cautious? Circulation.
109:701–705. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steffel J, Eberli FR, Lüscher TF and
Tanner FC: Drug-eluting stents - what should be improved? Ann Med.
40:242–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stone GW, Moses JW, Ellis SG, et al:
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary
stents. N Engl J Med. 356:998–1008. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wykrzykowska JJ, Serruys PW, Onuma Y, et
al: Impact of vessel size on angiographic and clinical outcomes of
revascularization with biolimus-eluting stent with biodegradable
polymer and sirolimus-eluting stent with durable polymer: the
LEADERS trial substudy. JACC Cardiovasc Interv. 2:861–870. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chevalier B, Silber S, Park SJ, et al;
NOBORI 1 Clinical Investigators. Randomized comparison of the
Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté
paclitaxel-eluting coronary stent in patients with stenosis in
native coronary arteries: the NOBORI 1 trial - Phase 2. Circ
Cardiovasc Interv. 2:188–195. 2009.
|
|
21
|
Floyd KC, Jayne JE, Kaplan AV, et al:
Age-based differences of percutaneous coronary intervention in the
drug-eluting stent era. J Interv Cardiol. 19:381–387. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Li CX, Wang HC, et al: Efficacy and
safety of Firebird sirolimus-eluting stent in treatment of complex
coronary lesions in Chinese patients: one-year clinical and
eight-month angiographic outcomes from the FIREMAN registry. Chin
Med J (Engl). 124:817–824. 2011.PubMed/NCBI
|
|
23
|
Yu M, Zhou YJ, Wang ZJ, et al: A
comparison of clinical outcomes of Chinese sirolimus-eluting stents
versus foreign sirolimus-eluting stents for the treatment of
coronary artery disease. Neth Heart J. 19:418–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
